LumiraDx Email Format
Hospitals and Health CareEngland, United Kingdom201-500 Employees
LumiraDx is a mid-sized healthcare company headquartered in London, England, operating within the hospitals and health care sector. The firm centers on a next-generation point-of-care platform technology designed to enable rapid diagnostics at the point of care, with a focus on clinical and hospital settings. Its offerings aim to provide healthcare providers with timely, on-site diagnostic information to support patient care. In December 2023, Roche Diagnostics announced it would acquire LumiraDx's point-of-care platform technology, transferring ownership of the technology to Roche. This move places the platform within Roche's broader diagnostics portfolio and aligns with its emphasis on personalized healthcare. The development reflects Roche's leadership in the field and signals how point-of-care technologies can be integrated into a larger pharmaceutical and diagnostics strategy.